Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
103577-45-3
Purity
95%
Lansoprazole decreases gastric acid secretion by targeting H+,K+-ATPase. Lansoprazole is used to reduce gastric acid secretion and is approved for short term treatment of active gastric ulcers, active duodenal ulcers, erosive reflux oesophagitis, symptomatic gastroesophageal reflux disease, and non-steroidal anti-inflammatory drug (NSAID) induced gastric and duodenal ulcers.
Properties
Name
Lansoprasole
Smiles
CC=1C(CS(=O)C2=NC=3C=CC=CC3N2)=NC=CC1OCC(F)(F)F
Targets
Please log in to see this information
SDS
Lansoprazole | lansoprasole
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$39
2 mg
$41
5 mg
$43
10 mg
$45
15 mg
$47
20 mg
$50
25 mg
$55
30 mg
$59
35 mg
$62
40 mg
$64
45 mg
$67
50 mg
$69
75 mg
$72
100 mg
$74
Quantity
1
Total amount
$ 43
Lansoprazole | lansoprasole
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:138530-94-6
0